Table 4 Risk factors for poor outcome by the breast surgeon’s JBCS Cosmetic Evaluation Scale
From: Outcomes of reconstructive techniques in breast cancer using BCCT. core software
Univariate analyses | Multivariate analyses | |||||
|---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Age | 1.01 | 0.97–1.05 | 0.62 | |||
Follow-up time | 1.012 | 1.004–1.021 | 0.003 | 1.02 | 1.01–1.03 | < 0.001 |
Tumor size | 1.036 | 1.004–1.068 | 0.027 | 1.02 | 0.98–1.06 | 0.24 |
Retrieved lymph node number | 1.044 | 1.002–1.087 | 0.041 | 1.04 | 0.99–1.08 | 0.94 |
Tumor localization (UOQ vs others) | 2.88 | 1.0–8.3 | 0.05 | 4.2 | 1.3–13.5 | 0.016 |
Radiation therapy | 0.57 | 0.18–1.81 | 0.34 | |||
Surgical Procedure | ||||||
BCS. vs mini LDF BCS vs M + I | 2.01 2.61 | 0.52–7.68 0.91–7.49 | 0.30 0.074 | |||